Navigation Links
Advanced Life Sciences Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung Injury
Date:11/18/2010

CHICAGO, Nov. 18, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied to the U.S. Food and Drug Administration for orphan drug designation for ALS-886, a novel therapy to reduce and prevent tissue damage, for the treatment of Acute Respiratory Distress Syndrome (ARDS).

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

The FDA's U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders. Orphan Drug designation is awarded to compounds that offer potential therapeutic value in the treatment of rare diseases, defined as those affecting fewer than 200,000 Americans. This designation provides companies with financial and regulatory benefits such as eligibility for a special seven-year period of market exclusivity upon approval for the compound and indication with orphan designation, potential tax credits for research, potential grant funding for research and development, reduced filing fees for marketing applications, and assistance with clinical trial protocol review.

About ARDS

ARDS is a serious and life-threatening medical condition often caused by the inflammation and tissue damage associated with excess free radicals in the lungs. ARDS is usually treated with mechanical ventilation in the Intensive Care Unit.  Currently, there are no effective therapeutic treatme
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...
(Date:5/23/2013)... 2013 Ranbaxy Laboratories Limited ... Daiichi Sankyo Co., Ltd. (im Weiteren ... die Maßnahmen bekannt, die Ranbaxy in ... sich der Angelegenheiten der vorhergehenden Unternehmensführung ... Daiichi Sankyo unterstützt Ranbaxy ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... HILL, N.C., Dec. 5, 2011   New product launches ... It is critical for organizations to balance the dueling goals ... challenge that executives face is determining how much to invest, ... of the budget for primary care launch is ...
... OrbusNeich today announced that data published in the November ... is safe when accompanied by only 10 days of dual ... 49 patients treated with Genous, no patient had died or ... myocardial infarction or angiographic evidence of stent thrombosis (ST) ascribable ...
Cached Medicine Technology:Launch Spend Insights: Companies Now Invest More in Launch Year Than in Previous 3 Ramp-Up Years Combined 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 3
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 Pittsburgh-based ... allowing seniors to remain independent in their own homes ... Security Alert’s Director of Life Safety, recently commented on ... providers. He stated that although there are numerous ... Automated Security Alert is rare in that they are ...
(Date:5/23/2013)... Sunnyvale, CA (PRWEB) May 23, 2013 Footwear ... Dansko Vista Collection of sandals containing cork footbeds. ... Dansko has had consistently good sales for many years, and ... this spring and summer. , Dansko Shoes ... and the Vista Collection is no exception. Containing leather and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Kitchen ... hands-on cooking classes, the most advanced culinary technique series ... from class with the knowledge of how to purchase, ... and the health benefits of organic, local ingredients. The ... which are six hours each. The next series begins ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 When Teachers ... product donations to raise funds for the Moore, OK ... dollars worth of items that could be sold for ... However, the staff at Teachers Notebook were overwhelmed by ... pledged $1000.00 worth of materials within the first 12 ...
(Date:5/23/2013)... 911 Signal USA is attending the 2013 Police Fleet ... and run through May 24, 2013. , In addition to ... emergency vehicle lights and sirens, 911 Signal USA will ... expo. , The Charger has been equipped with the best ... seen by visiting 911 Signal USA during the expo at ...
Breaking Medicine News(10 mins):Health News:Automated Security Alert's New Medical Alarm Works Even In Power Outages 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 3Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:911 Signal USA Attends the 2013 Southwest Police Fleet Expo 2
... first Southern-style canned product ... American Heart Association, COLUMBUS, Ohio, Jan. 9 ... low fat and meatless, were the first,product line of ... savory,taste. Now, heart-healthy Sensibly Seasoned products also bear the ...
... can do quite a number on your teeth. Did ... 11 teaspoons of sugar per serving and,that most soft ... these acids can cause erosion, the loss of hard ... Terry, a Pennsylvania Dental Association (PDA),member and endodontist from ...
... WSB-TV Partner to Collect Bags at 25 Georgia Locations, ... private oncology/ hematology practice in the Southeast -- will team,up ... drive. The,event will be held at 25 GCS offices across ... p.m., "Totes 2 Tots" delivers new or nearly new ...
... lead to better prognosis, treatments, researchers say , , WEDNESDAY, ... on a handful of tiny ribonucleic acid (RNA) molecules ... travels to the lung and bone. , These "microRNAs" ... When they are missing, that allows the disease to ...
... combat mortality , , WEDNESDAY, Jan. 9 (HealthDay News) -- ... question the conventional wisdom of treating with corticosteroids, intensive ... called pentastarch. , The first study compared the ... septic shock and found no improvement in survival rates. ...
... of developmental disorder, researchers say , , WEDNESDAY, Jan. 9 (HealthDay ... risk for developing autism, a new study suggests. , The ... of the causes of a disorder that is turning out ... in its symptoms. Not only is autism complicated, its incidence ...
Cached Medicine News:Health News:Glory Foods Receives Heart Healthy Certification 2Health News:Keep a Watchful Eye on Sugary Beverage Consumption 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 2Health News:Tiny RNA Molecules Control Breast Cancer's Spread 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 4Health News:Standard Septic Shock Treatments Ineffective 2Health News:Standard Septic Shock Treatments Ineffective 3Health News:Standard Septic Shock Treatments Ineffective 4Health News:Chromosome Abnormalities Raise Risk for Autism 2Health News:Chromosome Abnormalities Raise Risk for Autism 3Health News:Chromosome Abnormalities Raise Risk for Autism 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: